Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07325253 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
A Phase 2 study of Pilot Study and PET/CT Imaging, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT07325253 is a Phase 2 study of Pilot Study and PET/CT Imaging that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07325253, a Phase 2 study of Pilot Study and PET/CT Imaging, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
Conditions Studied
Interventions
- DRUG [18F]-4FN
- OTHER PET-CT
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2030-01-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07325253
The ClinicalTrials.gov registry entry for NCT07325253 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pilot Study appearing as the primary indexed condition, and to 2 interventions - of which [18F]-4FN is the first listed.
NCT07325253 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07325253 about?
NCT07325253 is a clinical study titled "A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations". To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
What is the current status of trial NCT07325253?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2025-11-18. Estimated completion is 2030-01-03.
What conditions does trial NCT07325253 study?
This clinical trial studies the following conditions: Pilot Study, PET/CT Imaging, Host Disease Manifestation.
What interventions are being tested in trial NCT07325253?
The interventions under investigation include: [18F]-4FN (DRUG), PET-CT (OTHER).
Who is sponsoring clinical trial NCT07325253?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07325253 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pilot Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.